Sat, Nov 16, 2024 10:08 AM
Initial hiccups for Sebi’s online settlement calculator
A Flip by Avya Verma
Glenmark Pharmaceuticals Q2 Results 2024: Glenmark Pharmaceuticals declared its Q2 results on 14 Nov, 2024, reporting a significant turnaround with a profit of ₹354.21 crore. This is a remarkable recovery from the loss of ₹81.95 crore recorded in the same period last fiscal year. Additionally, the company’s topline increased by 7.06% year-on-year.
Open Flip
Sammaan Capital Q2 Results 2024: Sammaan Capital announced its Q2 results for 2024 on 14 Nov, revealing a significant loss of ₹2761 crore. This contrasts sharply with the profit of ₹297.98 crore reported in the same quarter of the previous fiscal year. Despite the financial setback, the company reported a revenue increase of 8.75% year-over-year, and a growth of 9.74%.
Open Flip
ITI Q2 Results 2024: On November 14, 2024, ITI announced its Q2 results, showcasing remarkable growth despite ongoing challenges. The company’s topline surged by an impressive 312.3% year-over-year, signaling a significant recovery in its operations. The reported loss for the quarter stood at ₹70.33 crore, which marks a decrease of 44.19% from the same period last year.
Open Flip
